Onconova Therapeutics
ONTX
#9639
Rank
โ‚น1.76 B
Marketcap
โ‚น84.08
Share price
-0.47%
Change (1 day)
-9.09%
Change (1 year)

Revenue for Onconova Therapeutics (ONTX)

Revenue in 2024 (TTM): โ‚น18.75 Million

According to Onconova Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น19.09 Million. In 2023 the company made a revenue of โ‚น18.81 Million an increase over the revenue in the year 2022 that were of โ‚น18.7 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Onconova Therapeutics from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น18.75 M-0.34%
2023 โ‚น18.81 M0.6%
2022 โ‚น18.7 M11.18%
2021 โ‚น16.82 M-0.43%
2020 โ‚น16.89 M-89.15%
2019 โ‚น0.15 B81.3%
2018 โ‚น85.86 M70.87%
2017 โ‚น50.25 M-86.67%
2016 โ‚น0.37 B-50.5%
2015 โ‚น0.76 B1401.52%
2014 โ‚น50.7 M-82.73%
2013 โ‚น0.29 B-88.39%
2012 โ‚น2.52 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น2.17 B 11,284.51%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น93.03 B 487,166.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.266 T 6,635,740.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น6.40 B 33,426.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น53.37 M 179.58%๐Ÿ‡บ๐Ÿ‡ธ USA